BSX vs OPAL · P/E 20, rev $16.75B vs P/E 26, rev $349.0M
Boston Scientific Corp (BSX) versus OPAL Fuels Inc (OPAL) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
OPAL Fuels Inc (OPAL) is a utilities - regulated gas company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported OPAL revenue for 2025-12-31 was $349.0M. Net income was $36.4M. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. OPAL currently screens at market cap $318.1M and trailing P/E 26.0.
Not investment advice. Open the BSX and OPAL stock pages for the full models.
Not investment advice.